Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Eur…
$2.92+3.91%
报价 2026-11-06
市值
$326.5M
EV
$488M
PE (TTM)
–
预期 PE
–
52 周区间距高点 -79.1%
$2.53$13.94
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
does not hit growth, cheap, or GARP pool
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Drug Manufacturers - Specialty & Generic| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| TLRYTilray Brands, Inc. | $326.5M | +3.9% | – | 30.1% | – | – | – | |
| EOLSEvolus, Inc. | $449.5M | +0.1% | +11.5% | 65.6% | – | – | – | |
| KMDAKamada Ltd. | $417.1M | +5.2% | – | 42.3% | 23.3x | 10.8x | – | |
| EMBCEmbecta Corp. | $350.7M | -2.2% | +4.3% | 59.9% | 3.3x | 5.8x | 1.8x | Cheap |
| SNDLSNDL Inc. | $346.4M | +2.5% | – | 19% | – | 8.8x | – | |
| ACBAurora Cannabis Inc. | $344.5M | +1.0% | – | -5.9% | – | – | – | |
| EBSEmergent BioSolutions Inc. | $310.7M | +3.6% | -9.4% | 49.4% | – | – | 4.3x | |
| CGCCanopy Growth Corporation | $275.8M | -3.6% | – | 27.4% | – | – | – | |
| LFCRLifecore Biomedical, Inc. | $241.1M | -0.6% | +62.7% | 29.7% | – | – | – | |
| 同行中位数 | – | – | +7.9% | 36% | 13.3x | 8.8x | 3.1x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
| Metric | 2026-08-31 Q1 2027 | 2026-05-31 Q4 2026 | 2026-02-28 Q3 2026 | 2025-11-30 Q2 2026 | 2025-08-31 Q1 2026 | 2025-05-31 Q4 2025 | 2025-02-28 Q3 2025 | 2024-11-30 Q2 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $257.1M | $281.7M | $206.7M | $217.5M | $209.5M | $224.5M | $185.8M | $211M |
| Gross Margin | 30.1% | 29.9% | 26.6% | 26.4% | 27.4% | 30.1% | 28% | 29% |
| Operating Margin | -9.4% | -1.6% | -12.8% | -10.2% | 1% | -643.1% | -409% | -20% |
| Net Income | $-43.1M | $-49.6M | $-26.6M | $-44.9M | $-322,000 | $-1.27B | $-789.4M | $-85.3M |
| Diluted EPS | -0.32 | -0.43 | -0.24 | -0.41 | -0 | -13.01 | -8.69 | -0.99 |
| Operating Cash Flow | $-16.5M | $-37.5M | $-22.2M | $-11.9M | $-1.8M | $-19.9M | $-5.1M | $-56.7M |